Clinical trials to watch now

We’re just a few months away from the end of the year, but pharmaceutical companies still need to release a steady stream of clinical trial results before then. Several companies — including Novo Nordisk (NVO), Viking Therapies (VKTX) and Amgen (AMGN) – expect to publish the results of their next generation of weight loss drugs. Plus CRISPR Therapies (CRSP) will share preliminary findings from a pilot study of CTX112, a genetically engineered cell therapy for cancer and autoimmune diseases. Meanwhile, Moderna (MRNA) may be about to launch a new product alongside the COVID-19 vaccine.

Check out all these and more clinical trials that you absolutely shouldn’t miss.